SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : taxloss selling
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (12)10/18/2000 11:24:14 AM
From: Extra Pale   of 16
 
Peter,
Thanks for the reminder about 10/31 fund year end. Bought INCY & INCY 3/01 calls -- per yahoo, INCY has cash of $625 million out of a market cap of $1800m; 63% institutional ownership; currently selling at ~20% of annual high. More importantly, has strong revenue growth and a very valuable IP portfolio plus a coherent business plan. Seems to be a lot of upside in this stock, especially at under $30/share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News